Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K M Zangwill

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The Journal of Infectious Diseases|April 1, 1994
Duration of antibody response after meningococcal polysaccharide vaccination in US Air Force personnelK M Zangwill, R W Stout, G M Carlone, et al.
Pediatrics|August 3, 2001
Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy childrenB R Luce, K M Zangwill, C S Palmer, et al.
The Pediatric Infectious Disease Journal|December 12, 2001
Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected childrenJ C King, P E Fast, K M Zangwill, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The Journal of Infectious Diseases|April 1, 1994
Duration of antibody response after meningococcal polysaccharide vaccination in US Air Force personnelK M Zangwill, R W Stout, G M Carlone, et al.
Pediatrics|August 3, 2001
Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy childrenB R Luce, K M Zangwill, C S Palmer, et al.
The Pediatric Infectious Disease Journal|December 12, 2001
Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected childrenJ C King, P E Fast, K M Zangwill, et al.
Pageof 2